title: Anti-heparin-platelet factor 4 antibodies are associated with arterial and venous thrombosis in patients with maintenance haemodialysis.
authors: Ying
authors: Y
authors: Tan
authors: Lei
authors: L
authors: Cao
authors: Ji-Cheng
authors: JC
authors: Lv
authors: Yu
authors: Y
authors: Yan
authors: Li
authors: L
authors: Zuo
authors: Mei
authors: M
authors: Wang
authors: Lu
authors: L
authors: Yu
authors: Feng
authors: F
authors: Yu
authors: Ming-Hui
authors: MH
authors: Zhao
mesh_terms: D000328:Adult; D000368:Aged; D000925:Anticoagulants / Q000009:adverse effects* / Q000276:immunology*; D002681:China; D003430:Cross-Sectional Studies; D005260:Female; D006493:Heparin / Q000009:adverse effects* / Q000276:immunology*; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D008297:Male; D008875:Middle Aged; D010978:Platelet Factor 4 / Q000276:immunology*; D006435:Renal Dialysis / Q000009:adverse effects*; D013927:Thrombosis / Q000097:blood / Q000209:etiology* / Q000276:immunology; D020246:Venous Thrombosis / Q000097:blood / Q000209:etiology / Q000276:immunology
chemical_list: D000925:Anticoagulants; D007074:Immunoglobulin G; D010978:Platelet Factor 4; D006493:Heparin